zepbound tirzepatide injection eli lilly Lilly's in shortage months after approval Big news! Eli Lilly just

Understanding GLP-1 medications beyond the Fella program Whether you choose Fella or another provider, understanding how GLP-1 medications work helps you get better results from any program

September 2025: Pfizer announced its agreement to acquire Metsera in a deal valued at up to USD 7.3 billion, strengthening its pipeline of next-generation GLP-1, amylin, and obesity therapies

Our healthcare providers are here to ensure that Tirzepatide is working effectively for you and to manage any side effects appropriately

Semaglutide has been studied for GLP-1 receptor signaling, incretin biology, central appetite regulation, beta-cell preservation, cardiovascular inflammation, NASH/NAFLD resolution, and neurodegenerative disease